Randomized, Double-blind, Active-controlled, Multi-center Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis.
Phase of Trial: Phase II
Latest Information Update: 05 Aug 2014
At a glance
- Drugs YH 4808 (Primary) ; Esomeprazole
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- Sponsors Yuhan
- 09 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jul 2013 Planned end date changed from 1 Oct 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 12 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.